Skip to main content

Table 1

From: Computational methods and resources for the interpretation of genomic variants in cancer

Cancer Type

Donors

Total Unique Mutations

Total Recurrent Mutations

Donors with Recurrent Mutations

BLCA

233

53,638

737 (1.4%)

219 (94.0%)

BOCA

66

1,422

7 (0.5%)

39 (59.1%)

BRCA

1,071

275,612

1,252 (0.5%)

929 (86.7%)

CLLE

109

5,292

4 (0.1%)

10 (9.2%)

CMDI

129

86

13 (15.1%)

113 (87.6%)

COAD

216

105,786

3,896 (3.7%)

215 (99.5%)

EOPC

11

25,575

2 (0.0%)

4 (36.4%)

ESAD

95

1,780,883

25,425 (1.4%)

95 (100.0%)

ESCA

88

7,256

17 (0.2%)

37 (42.0%)

GACA

9

1,014

0 (0.0%)

0 (0.0%)

GBM

268

19,852

324 (1.6%)

260 (97.0%)

KIRC

404

26,371

688 (2.6%)

372 (92.1%)

KIRP

156

12,932

218 (1.7%)

144 (92.3%)

LAML

75

60,203

7,623 (12.7%)

71 (94.7%)

LGG

279

13,083

432 (3.3%)

278 (99.6%)

LIAD

30

917

11 (1.2%)

19 (63.3%)

LICA

29

747,334

27,107 (3.6%)

6 (20.7%)

LINC

244

437,403

6003 (1.4%)

244 (100.0%)

LIRI

208

2,124,689

4161 (0.2%)

208 (100.0%)

LUSC

289

125,351

1400 (1.1%)

268 (92.7%)

MALY

44

311,297

686 (0.2%)

44 (100.0%)

NBL

41

137

2 (1.5%)

4 (9.8%)

ORCA

50

5,604

35 (0.6%)

38 (76.0%)

OV

181

919,769

869 (0.1%)

119 (65.7%)

PACA

504

1,630,944

6,098 (0.4%)

500 (96.5%)

PAEN

35

112,823

804 (0.7%)

32 (91.4%)

PBCA

248

130,608

1,231 (0.9%)

89 (35.9%)

PRAD

264

90,599

776 (0.9%)

256 (96.7%)

READ

80

23,499

556 (2.4%)

80 (100.0%)

RECA

105

475,986

6,067 (1.3%)

95 (90.5%)

SKCM

323

226,850

11,908 (5.2%)

323 (100.0%)

STAD

289

142,496

3,441 (2.4%)

276 (95.5%)

THCA

411

51,759

4,619 (8.9%)

311 (75.7%)

PanCancer

6,584

9,871,474

171,314 (1.7%)

6,296 (95.6%)

  1. Somatic mutations in 33 tumor types from 42 projects from the ICGC release 17 (September 2014). Donors: total number of individual for each tumor type. Total Unique Mutations: number of somatic mutations in the whole genome for each cancer type removing repetitions. Total Recurrent Mutations: fraction of Total Unique Mutations observed at least in two donors for the same tumor type. Donors with Recurrent Mutations: fraction of donors with at least one recurrent somatic mutation.